TERNS PHARMACEUTICALS INC (TERN)
Institutional ownership reported to the SEC as of Q2 2026, across 22 quarters.
2
Reporting holders
$659.7K
Reported value
0.0%
Held as options
-309
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| MIZUHO SECURITIES USA LLC | $584.3K | 11,083 | 0.01% | 2q | HELD |
| IFP Advisors, Inc | $75.4K | 1,424 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $659.7K | 12,507 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 311 | $7.0B | 119,369,879 | 123 | 110 | 53 | 9.9% |
| Q4 2025 | 236 | $4.9B | 118,527,108 | 108 | 68 | 41 | 1.5% |
| Q3 2025 | 137 | $675.3M | 89,199,363 | 26 | 39 | 41 | 0.8% |
| Q2 2025 | 125 | $311.5M | 83,182,651 | 23 | 45 | 30 | 0.4% |
| Q1 2025 | 135 | $229.4M | 82,632,117 | 22 | 41 | 37 | 0.5% |
| Q4 2024 | 149 | $472.7M | 84,548,245 | 26 | 62 | 30 | 0.9% |
| Q3 2024 | 146 | $648.7M | 76,307,375 | 47 | 48 | 36 | 1.9% |
| Q2 2024 | 121 | $451.5M | 65,660,831 | 37 | 43 | 23 | 1.0% |
| Q1 2024 | 106 | $425.3M | 64,617,164 | 25 | 31 | 32 | 0.3% |
| Q4 2023 | 98 | $426.4M | 65,439,832 | 18 | 32 | 17 | 0.4% |
| Q3 2023 | 91 | $310.9M | 61,395,138 | 9 | 28 | 35 | 0.7% |
| Q2 2023 | 98 | $517.9M | 57,595,107 | 41 | 28 | 22 | 2.7% |
| Q1 2023 | 73 | $706.6M | 59,677,618 | 26 | 27 | 11 | 0.0% |
| Q4 2022 | 53 | $406.5M | 39,930,681 | 21 | 17 | 10 | 0.0% |
| Q3 2022 | 45 | $178.1M | 30,289,272 | 18 | 16 | 7 | 0.0% |
| Q2 2022 | 38 | $36.6M | 14,722,313 | 11 | 11 | 11 | 0.0% |
| Q1 2022 | 43 | $50.0M | 16,836,162 | 6 | 10 | 14 | 0.0% |
| Q4 2021 | 37 | $116.7M | 16,503,387 | 7 | 15 | 6 | 0.0% |
| Q3 2021 | 33 | $174.3M | 16,725,042 | 2 | 15 | 6 | 0.0% |
| Q2 2021 | 36 | $203.8M | 16,621,277 | 6 | 11 | 11 | 0.0% |
| Q1 2021 | 42 | $393.7M | 17,905,568 | 42 | 0 | 0 | 0.0% |